Impedimed (Australia) Price Patterns
| IPD Stock | 0.02 0 4.55% |
Momentum 43
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (0.01) | EPS Estimate Next Year (0) | Wall Street Target Price 0.0838 | Quarterly Revenue Growth 0.213 |
Using Impedimed hype-based prediction, you can estimate the value of Impedimed from the perspective of Impedimed response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Impedimed to buy its stock at a price that has no basis in reality. In that case, they are not buying Impedimed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Impedimed after-hype prediction price | AUD 0.029 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Impedimed |
Impedimed After-Hype Price Density Analysis
As far as predicting the price of Impedimed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Impedimed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Impedimed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Impedimed Estimiated After-Hype Price Volatility
In the context of predicting Impedimed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Impedimed's historical news coverage. Impedimed's after-hype downside and upside margins for the prediction period are 0.00 and 4.94, respectively. We have considered Impedimed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Impedimed is out of control at this time. Analysis and calculation of next after-hype price of Impedimed is based on 3 months time horizon.
Impedimed Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Impedimed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Impedimed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Impedimed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.64 | 4.91 | 0.02 | 0.09 | 8 Events / Month | 2 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.02 | 0.03 | 26.05 |
|
Impedimed Hype Timeline
Impedimed is currently traded for 0.02on Australian Securities Exchange of Australia. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.09. Impedimed is forecasted to increase in value after the next headline, with the price projected to jump to 0.029 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is anticipated to be 26.05%, whereas the daily expected return is currently at -0.64%. The volatility of related hype on Impedimed is about 3541.93%, with the expected price after the next announcement by competition of 0.11. Impedimed has accumulated 14.49 M in total debt. Debt can assist Impedimed until it has trouble settling it off, either with new capital or with free cash flow. So, Impedimed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Impedimed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Impedimed to invest in growth at high rates of return. When we think about Impedimed's use of debt, we should always consider it together with cash and equity.Assuming the 90 days trading horizon the next forecasted press release will be in about 8 days. Check out Impedimed Basic Forecasting Models to cross-verify your projections.Impedimed Related Hype Analysis
Having access to credible news sources related to Impedimed's direct competition is more important than ever and may enhance your ability to predict Impedimed's future price movements. Getting to know how Impedimed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Impedimed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EMV | Emvision Medical Devices | 0.00 | 2 per month | 0.00 | (0.06) | 4.00 | (3.14) | 9.98 | |
| DPM | Dpm Metals | 0.88 | 7 per month | 1.27 | 0.33 | 4.11 | (2.60) | 9.04 | |
| EYE | Nova EYE Medical | (0.01) | 4 per month | 3.95 | 0.03 | 7.69 | (7.14) | 19.17 | |
| SLB | Stelar Metals | (0) | 5 per month | 0.00 | (0.1) | 4.55 | (7.89) | 19.09 | |
| MBH | Maggie Beer Holdings | 0.00 | 5 per month | 3.64 | 0.06 | 8.99 | (9.09) | 26.00 | |
| OSL | Oncosil Medical | 0.02 | 3 per month | 0.00 | (0.24) | 7.14 | (7.22) | 15.94 | |
| CYL | Catalyst Metals | 0.23 | 7 per month | 2.77 | 0.13 | 7.11 | (4.27) | 18.38 | |
| AMI | Aurelia Metals | (0.01) | 6 per month | 3.07 | 0.15 | 7.69 | (4.17) | 13.26 |
Impedimed Additional Predictive Modules
Most predictive techniques to examine Impedimed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Impedimed using various technical indicators. When you analyze Impedimed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Impedimed Predictive Indicators
The successful prediction of Impedimed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Impedimed, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Impedimed based on analysis of Impedimed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Impedimed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Impedimed's related companies.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Impedimed Stock Analysis
When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.